GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bioneer 064550.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

6,620

+4.25%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩330.11bn

FY2016FY2025

Net income

−₩2.81bn

FY2016FY2025

Free cash flow

₩3.17bn

FY2016FY2025

Shareholders' equity

₩209.68bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩330.11bn₩293.98bn₩263.24bn₩218.39bn₩223.74bn₩206.99bn₩36.29bn₩24.08bn₩23.27bn₩21.70bn
Gross profit₩257.23bn₩219.93bn₩203.01bn₩166.65bn₩174.20bn₩162.59bn₩19.15bn₩12.93bn₩13.62bn₩11.54bn
Research and development₩12.81bn₩19.17bn₩15.03bn₩16.75bn₩17.99bn₩13.12bn—₩10.42bn₩8.07bn₩8.47bn
Operating income₩12.66bn−₩13.54bn₩826.9m—₩47.11bn₩105.22bn−₩9.41bn−₩13.63bn−₩7.11bn−₩12.55bn
Net income−₩2.81bn−₩20.58bn−₩10.59bn₩12.08bn₩27.16bn₩57.90bn−₩7.83bn−₩8.82bn−₩9.87bn−₩14.42bn
Diluted earnings per share-108.99-797.52-410.19467.911,052.282,296.53-351.59-427.59-715.76-832.65

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩369.88bn₩332.19bn₩315.49bn₩298.74bn₩262.42bn₩191.17bn₩82.10bn₩70.81bn₩58.70bn₩63.71bn
Cash and short-term investments———₩80.03bn₩79.68bn₩59.82bn₩25.24bn₩14.72bn₩9.29bn₩3.88bn
Total liabilities₩142.90bn₩105.29bn₩80.61bn₩62.74bn₩59.37bn₩45.56bn₩51.49bn₩31.82bn₩31.55bn₩37.59bn
Debt₩60.14bn₩73.72bn₩44.64bn₩27.87bn₩21.02bn₩13.54bn₩27.02bn₩18.44bn₩18.88bn₩24.89bn
Shareholders' equity₩209.68bn₩213.92bn₩223.88bn₩236.00bn₩203.05bn₩145.61bn₩30.61bn₩38.99bn₩27.15bn₩26.11bn
Shares outstanding26m26m26m26m26m25m22m21m14m17m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩10.33bn−₩13.48bn₩4.14bn₩8.81bn₩53.17bn₩95.71bn−₩5.59bn−₩8.11bn−₩3.90bn−₩4.09bn
Capital spending−₩7.16bn−₩12.63bn−₩4.66bn−₩18.52bn−₩42.18bn−₩54.52bn−₩4.41bn−₩3.70bn−₩1.49bn−₩6.39bn
Free cash flow₩3.17bn−₩26.11bn−₩523.9m−₩9.72bn₩11.00bn₩41.19bn−₩10.00bn−₩11.81bn−₩5.40bn−₩10.48bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩96.15bn₩81.81bn₩79.85bn₩88.07bn₩88.28bn₩73.91bn₩70.43bn₩65.88bn
Gross profit₩74.62bn₩63.18bn₩58.50bn₩69.17bn₩70.91bn₩58.65bn₩49.10bn₩48.93bn
Operating income₩1.20bn−₩555.8m₩2.67bn₩2.86bn₩4.23bn₩4.34bn−₩8.46bn−₩9.11bn
Net income−₩1.94bn−₩3.15bn−₩588.5m−₩994.4m−₩1.10bn−₩126.7m−₩6.75bn−₩9.98bn
Diluted earnings per share-75.14-122.07-22.80-38.53-42.76-4.91-261.44-386.80
Cash from operations−₩4.04bn₩6.68bn−₩8.04bn₩860.0m₩13.38bn₩4.13bn−₩13.48bn−₩11.32bn
Capital spending−₩1.79bn−₩1.45bn−₩1.83bn−₩778.0m—−₩45.89bn−₩12.63bn−₩962.0m
Free cash flow−₩5.83bn₩5.22bn−₩9.86bn₩82.0m—−₩41.75bn−₩26.11bn−₩12.29bn
Total assets₩369.32bn₩368.98bn₩369.88bn₩376.52bn₩375.40bn₩368.40bn₩332.19bn₩332.21bn
Cash and short-term investments—————₩83.59bn₩54.24bn₩64.00bn
Debt₩58.76bn₩59.45bn₩60.14bn₩60.83bn₩61.52bn₩105.66bn₩69.49bn₩68.10bn
Shareholders' equity₩204.01bn₩205.44bn₩209.68bn₩212.34bn₩213.97bn₩213.75bn₩213.92bn₩209.89bn

Financial ratios

Data as of 2 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin77.9%74.8%77.1%76.3%77.9%78.5%———
Operating margin3.8%-4.6%0.3%—21.1%50.8%-23.5%——
Net margin-0.9%-7.0%-4.0%5.5%12.1%28.0%———
Return on equity-1.3%-9.6%-4.7%5.1%13.4%39.8%———
Return on assets-0.8%-6.2%-3.4%4.0%10.3%30.3%———
Free cash flow yield———————-2.2%-1.8%
Revenue growth12.3%11.7%20.5%-2.4%8.1%470.3%———
Earnings growth-86.3%94.4%-187.7%-55.5%-53.1%-839.8%———
Current ratio2.25x2.26x2.75x3.70x2.69x2.73x———
Debt to equity0.29x0.12x0.06x0.11x0.10x0.05x———
Equity ratio56.7%64.4%71.0%79.0%77.4%76.2%———
Interest coverage2.74x-3.96x0.59x—73.45x52.67x———
R&D as a share of sales3.9%6.5%5.7%7.7%8.0%6.3%———
Buybacks as a share of market value———————-49.5%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue14.8%9.8%31.8%
Operating income—-34.5%—
Net income——-6.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin76.5%76.6%77.0%75.4%
Operating margin-0.1%———
Net margin-3.7%-2.0%4.1%1.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-117.0-23.6-81.262.846.27.7-19.3-17.4-12.6-8.2
Price to sales1.01.63.33.55.62.24.26.45.35.5

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.